期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 474, 期 2-3, 页码 195-198出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/S0014-2999(03)02074-0
关键词
cannabinoid; microglial cell; migration; inflammation
资金
- NIDA NIH HHS [DA 14486] Funding Source: Medline
Microglial cells, the macrophages of the brain, express low, yet detectable levels of cannabinoid CB, receptors, which are known to modulate cell migration. To determine if cannabinoid CB, receptors expressed by microglial cells modulate their migration, we assessed whether arachidonylcyclopropylamide (ACPA, an agonist shown to selectively activate CB, receptors) affects the migration of BV-2 cells, a mouse microglial cell line. We found that ACPA induced a dose-dependent increase in BV-2 cell migration (EC50 = 2.2 nM). This ACPA response was blocked by pertussis toxin pretreatment, suggesting the involvement of G(i/o) protein-coupled receptors. However, the cannabinoid CB1 receptor antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide-hydrochloride (SR141716A) did not prevent ACPA-induced BV-2 cell migration. Two antagonists of cannabinoid CB2 receptors N-(1,S)-endo-1,3,3-trimethyl bicyclo(2,2,1)heptan-2-yl)-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide (SR144528) and cannabinol, as well as two antagonists of the newly identified abnormal-cannabidiol-sensitive (abn-CBD) receptors (O-1918 and cannabidiol) prevented this response. Our results suggest that cannabinoid CB2 receptors and abn-CBD receptors, rather than cannabinoid CB1 receptors, regulate microglial cell migration, and that ACPA is a broad cannabinoid receptor agonist. (C) 2003 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据